Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen Inc. | -0.24% | 343.28 | 1.2% | $589.37m | |
| GILD | Gilead Sciences, Inc. | 1.33% | 73.32 | 0.9% | $534.10m | |
| CELG | Celgene Corporation | 0.35% | 91.20 | 1.2% | $502.04m | |
| AMGN | Amgen Inc. | -0.13% | 197.31 | 1.2% | $470.98m | |
| ILMN | Illumina, Inc. | 1.67% | 331.44 | 3.5% | $390.25m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.00% | 378.56 | 2.6% | $309.76m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.65% | 176.86 | 1.9% | $202.70m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.71% | 116.99 | 2.0% | $186.49m | |
| A | Agilent Technologies, Inc. | 0.75% | 64.95 | 1.5% | $163.20m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.18% | 129.14 | 16.6% | $139.77m | |
| NKTR | Nektar Therapeutics | 2.24% | 61.96 | 5.6% | $128.47m | |
| EXAS | Exact Sciences Corporation | 1.71% | 50.05 | 25.3% | $122.85m | |
| BLUE | Bluebird Bio, Inc. | 0.06% | 158.80 | 14.6% | $120.19m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.72% | 99.74 | 4.4% | $119.07m | |
| INCY | Incyte Corporation | 0.83% | 69.62 | 2.5% | $116.18m |
Company Profile
Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT.